NASH is increasing with the current obesity pandemic. Prof. Robert Chilton (San Antonio – USA) reminds us that the current best practices to tackle the burden of this multi-system disease are currently lifestyle interventions (including weight loss and maintaining a healthy lifestyle while adhering to the guideline treatments of CV risk factors). He reviews se risk factors, association and latest clinical considerations of NASH and cardiovascular disease. He also discusses the potential role of a PanPPAR approach.
